Proinflammatory and cytotoxic response to nanoparticles in precision-cut lung slices by Hirn, Stephanie et al.
2440
Proinflammatory and cytotoxic response to nanoparticles in
precision-cut lung slices
Stephanie Hirn*1, Nadine Haberl1, Kateryna Loza2, Matthias Epple2,
Wolfgang G. Kreyling3, Barbara Rothen-Rutishauser4, Markus Rehberg1
and Fritz Krombach1
Full Research Paper Open Access
Address:
1Walter Brendel Centre of Experimental Medicine,
Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377
Munich, Germany, 2Inorganic Chemistry and Center of
Nanointegration Duisburg-Essen (CeNIDE), University of
Duisburg-Essen, Universitätsstr. 5-7, 45117 Essen, Germany,
3Institute of Epidemiology 2, Helmholtz Center Munich, Ingolstädter
Landstr. 1, 85764 Neuherberg/Munich, Germany and 4Adolphe
Merkle Institute, Université de Fribourg, Route de l'ancienne
Papeterie CP 209, 1723 Marly, Switzerland
Email:
Stephanie Hirn* - Stephanie.hirn@med.uni-muenchen.de
* Corresponding author
Keywords:
cytokines; cytotoxicity; ex vivo; lung slices; nanoparticles
Beilstein J. Nanotechnol. 2014, 5, 2440–2449.
doi:10.3762/bjnano.5.253
Received: 19 March 2014
Accepted: 25 November 2014
Published: 18 December 2014
This article is part of the Thematic Series "Biological responses to NPs".
Guest Editor: R. Zellner
© 2014 Hirn et al; licensee Beilstein-Institut.
License and terms: see end of document.
Abstract
Precision-cut lung slices (PCLS) are an established ex vivo alternative to in vivo experiments in pharmacotoxicology. The aim of
this study was to evaluate the potential of PCLS as a tool in nanotoxicology studies. Silver (Ag-NPs) and zinc oxide (ZnO-NPs)
nanoparticles as well as quartz particles were used because these materials have been previously shown in several in vitro and in
vivo studies to induce a dose-dependent cytotoxic and inflammatory response. PCLS were exposed to three concentrations of 70 nm
monodisperse polyvinylpyrrolidone (PVP)-coated Ag-NPs under submerged culture conditions in vitro. ZnO-NPs (NM110) served
as ‘soluble’ and quartz particles (Min-U-Sil) as ‘non-soluble’ control particles. After 4 and 24 h, the cell viability and the release of
proinflammatory cytokines was measured. In addition, multiphoton microscopy was employed to assess the localization of Ag-NPs
in PCLS after 24 h of incubation. Exposure of PCLS to ZnO-NPs for 4 and 24 h resulted in a strong decrease in cell viability, while
quartz particles had no cytotoxic effect. Moreover, only a slight cytotoxic response was detected by LDH release after incubation of
PCLS with 20 or 30 µg/mL of Ag-NPs. Interestingly, none of the particles tested induced a proinflammatory response in PCLS.
Finally, multiphoton microscopy revealed that the Ag-NP were predominantly localized at the cut surface and only to a much lower
extent in the deeper layers of the PCLS. In summary, only ‘soluble’ ZnO-NPs elicited a strong cytotoxic response. Therefore, we
suggest that the cytotoxic response in PCLS was caused by released Zn2+ ions rather than by the ZnO-NPs themselves. Moreover,
Ag-NPs were predominantly localized at the cut surface of PCLS but not in deeper regions, indicating that the majority of the parti-
cles did not have the chance to interact with all cells present in the tissue slice. In conclusion, our findings suggest that PCLS may
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have some limitations when used for nanotoxicology studies. To strengthen this conclusion, however, other NP types and concen-
trations need to be tested in further studies.
Introduction
Nanoparticles (NPs) are defined as materials with one dimen-
sion between 1–100 nm that occur naturally or anthropogeni-
cally. The class of synthetic NPs can be subdivided in inci-
dental NPs that are generated as byproducts of combustion
processes (e.g., in diesel exhaust) and engineered NPs (ENPs)
that are specifically manufactured. The synthesis of ENPs
allows one to control the properties of NPs such as size, shape,
or chemical composition. As nanotechnology is a tremendously
growing field with high commercial interest, ENPs are already
used in several areas such as car industry, power engineering,
optics, cosmetics, medicine, and pharmaceutics. This wide
application range also raises questions about the safety of ENPs.
Toxicological testing for most commercial ENPs is missing so
far as there is no regulation for the fabrication and declaration
of ENPs in consumer products. Assigned with the task to deter-
mine potential health risk effects of ENPs, nanotoxicology is a
rapidly emerging research area [1]. There are several in vitro
and in vivo models for testing the toxicity of nanoparticles. In
vitro test systems, offering the advantages of easy handling and
high-trough-put screening, can provide a first estimation of
possible toxic effects. However, cell culture systems do not
adequately reflect the real in vivo situation, whereas animal
experiments are elaborative, cost-intensive, and the transfer-
ability from animal to human is often difficult. Furthermore, the
aspect of the three “R’s” (replacement, refinement, and reduc-
tion of animal experiments) makes the development of in vitro
or ex vivo alternatives a worthwhile objective [2,3]. Therefore,
tissue slices can be an alternative to in vitro and in vivo studies
[4]. Precision-cut lung slices (PCLS) are already used as an
alternative ex vivo model in lung pharmacotoxicology [5]. As
the lungs are also an important primary target organ for
aerosolized ENPs, PCLS could have the potential to serve as an
efficient tool in nanotoxicology. PCLS can be prepared from
several species such as mouse or rat, but also from human lung
tissue [6]. A major advantage of this tissue model is the reten-
tion of the lung architecture. The conservation of intact cells,
including alveolar epithelial cells, alveolar macrophages, and
dendritic cells, in their natural context has been shown in
several studies by immunohistochemical staining [7-9]. Never-
theless, this in vitro system has also its limitations. There are
obvious disadvantages in comparison to the in vivo situation
such as no ventilation, no stretching, and no perfusion of the
tissue. Moreover, dead cells are present at the slice surface due
to the cutting process [10]. However, airway dynamics are
preserved in PCLS which allows the monitoring of bronchocon-
striction triggered by chemical stimuli [11-13].
So far, PCLS are already used in pharmacotoxicology studies to
determine the response to allergens, chemicals, tobacco smoke,
engine emissions, or oxidant air pollutions [5]. These studies
mostly focused on the evaluation of airway constriction in
PCLS caused by the tested substances [11,13,14]. Despite their
established usage in pharmacotoxicology, there are only a few
studies using PCLS in the field of nanotoxicology, yet. It was
demonstrated that solid lipid NPs induced a cytotoxic response
in PCLS, but only at very high concentrations (1 mg/mL and
higher) [15-18]. Wohlleben et al. reported that a cobalt ferrite
nanomaterial elicited a dose-dependent cytotoxicity as deter-
mined by the water-soluble tetrazolium salt (WST-1) assay and
that incubation of PCLS with carbon nanotubes did not induce a
cytotoxic response, whereas exposure to ZnO-NPs induced a
strong cytotoxic response in PCLS [19,20].
The aim of the present study was to investigate whether PCLS
have the potential to serve as a generally applicable effective
tool in nanotoxicology. First, we determined the viability of
PCLS up to 72 h by carrying out live/dead staining, lactate
dehydrogenase (LDH) assay, and WST-1 assay. Second, we
assessed the cytotoxic and proinflammatory response of PCLS
to Ag-NPs through LDH assay, WST-1 assay, and ELISA assay
for CXCL-1 and tumour necrosis factor-α (TNF-α) release.
ZnO-NPs served as a soluble control and quartz particles as a
non-soluble control, since both particle types have induced
cytotoxic as well as inflammatory responses in in vitro as well
as in vivo assays.
Results
Particle characterization
The mean hydrodynamic diameter of the Ag-NPs as deter-
mined by dynamic light scattering (DLS) was 116 nm and the
polydispersity index (PDI) was below 0.3 for all measurements.
The mean diameter of the metallic core as determined by scan-
ning electron microscopy (SEM) was 65 nm. Furthermore, the
mean hydrodynamic diameter of the Ag-NPs in culture medium
(DMEM/F-12 Ham) as measured by DLS was 120 nm. The
mean hydrodynamic diameter of the uncoated ZnO-NP
(NM-110) in distilled water and culture medium was 413 nm
and 271 nm and that of the quartz particles 1114 nm and
1843 nm, respectively.
Viability of PCLS
PCLS with a thickness of 250 µm were prepared from Wistar
rats and subsequently cultured in DMEM/F-12 Ham. Viability
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was determined at 4, 24, 48, and 72 h after incubation in
medium by three different test assays: LDH-assay, live/dead
staining, and WST-1 assay.
As LDH is present in the cytoplasm of cells, detection of LDH
in the culture medium of PCLS indicates a loss of cell
membrane integrity. Therefore, LDH release is a direct measure
of a cytotoxic response or an indirect measure of cell viability.
As displayed in Figure 1, the LDH release slightly increased
over time, reaching 14% of total LDH after 72 h.
Figure 1: Cell viability as measured by LDH release in PCLS culture
medium at 0, 4, 24, 48, and 72 h after preparation of PCLS. Results
were calculated as percentage of the positive control (Triton X-100-
lysed PCLS) (n = 5; #p < 0.05 vs 0 h; $p < 0.05 vs 4 h determined by
ANOVA on ranks with post hoc Tukey test).
To corroborate the findings revealed by the LDH assay, we
used live/dead staining as an additional viability test. While the
ratio of spots (nuclei of dead cells)/volume (cytoplasm of living
cells) did not change between 4 and 24 h of incubation, the ratio
of spots/volume was doubled after 48 and 72 h indicating a
slight decrease in viability over time (Table 1).
Table 1: Viability of PCLS determined by live/dead staining at 4, 24,
48, and 72 h after preparation of PCLS.
culture time nuclei (diameter ≥ 4 µm)/volume (105 µm3)
4 h 14 ± 1.4
24 h 13 ± 3.0
48 h 27 ± 1.2a
72 h 29 ± 1.9a
ap < 0.05 vs 4 and 24 h; determined by one-way repeated measures
ANOVA with post hoc Tukey test.
In a third viability test, the mitochondrial activity was measured
by using WST-1 conversion. Interestingly, the mitochondrial
activity increased after 24 h and persisted up to 72 h (Figure 2).
Figure 2: Viability of PCLS as determined by WST-1 conversion at 0,
4, 24, 48, and 72 h after preparation of PCLS (n = 5; *p < 0.05 vs 0 h;
§p < 0.05 vs 4 h determined by one-way ANOVA with post hoc Tukey
test).
Since an increased WST-1 conversion could also indicate cell
proliferation, we examined if there was enhanced cell prolifera-
tion by performing a proliferation assay (Click-iT® EdU Alexa
Fluor® 488 Imaging Kit) in which the incorporation of
5-ethynyl-2′-deoxyuridine, a nucleoside analogue to thymidine,
into replicated DNA can be visualized by confocal laser scan-
ning microscopy. As shown in Figure 3, cell proliferation was
not significantly altered as shown by this assay.
Figure 3: Cell proliferation in PCLS as determined by Click-iT® EdU
Alexa Fluor® 488 Imaging Kit (Invitrogen) at four different time frames
(n = 4 PCLS per time point, three different areas; no significant
differences).
Responses of PCLS after exposure to
(nano)particles
Cytotoxic response
After 4 h of incubation with 20 and 30 µg/mL Ag-NPs, the
LDH release was slightly increased to 4%, while exposure to
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Figure 6: A: CXCL-1 levels measured in the PCLS culture medium after 4 and 24 h of incubation; B: TNF-α-levels measured in the PCLS culture
medium after 4 and 24 h of incubation; n = 5; #p < 0.05 vs control determined by ANOVA on ranks with post hoc Student–Newman–Keuls test.
ZnO-NPs and quartz particles did not result in increased LDH
levels, indicating no cytotoxic response to these particles at this
early time point. However, after incubation over 24 h, exposure
to Ag-NPs caused a dose-dependent increase in LDH release of
8% and 13% after exposure to 20 and 30 µg/mL Ag-NPs, res-
pectively. Moreover, 24 h of incubation with ZnO-NPs elicited
a strong LDH release of 28%, while quartz particles did not in-
duce a cytotoxic response (Figure 4).
Figure 4: Cytotoxic response of PCLS as measured by LDH release
after 4 and 24 h incubation. Results were calculated as percentage
of the total LDH content, while Triton X-100 (Triton) lysed PCLS
served as positive control with 100% LDH release (n = 5; #p < 0.05 vs
control determined by ANOVA on ranks with post hoc
Student–Newman–Keuls test).
WST-1 conversion was measured as an additional cytotoxicity
test. The mitochondrial activity did not change significantly
after 4 and 24 h of incubation with Ag-NPs and quartz particles
in comparison to controls. However, WST-1 conversion was
decreased after 4 and 24 h of exposure to ZnO-NPs to 47% and
to positive control level (PCLS treated with 1% Triton-X), res-
pectively, again indicating a strong cytotoxic effect of these
particles (Figure 5).
Figure 5: Cytotoxic response of PCLS as measured by WST-1 conver-
sion after 4 and 24 h incubation (n = 5; #p < 0.05 vs control deter-
mined by ANOVA on ranks with post hoc Student–Newman–Keuls
test).
Proinflammatory response
The proinflammatory response in PCLS to NPs was quantified
by measuring the levels of CXCL-1 and TNF-α in the PCLS
culture medium through ELISA. The CXCL-1 release was not
affected by incubation with Ag-NPs and quartz particles, while
exposure to ZnO-NPs induced a slight decrease after 4 h of
incubation. Exposure to lipopolysaccharide (LPS, positive
control) elicited an increase in CXCL-1 levels after 4 h
(Figure 6A). The release of TNF-α after 4 h was slightly
decreased upon incubation with 30 µg/mL Ag-NPs, quartz
particles, and ZnO-NPs, while LPS induced a strong increase in
TNF-α levels. Whereas incubation of PCLS with Ag-NPs or
quartz particles for 24 h did not induce a change in TNF-α
levels, exposure to ZnO-NPs again resulted in a slight decrease
in comparison to control levels (Figure 6B).
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Figure 7: Multiphoton microscopy of Ag-NPs in the lung tissue. Image of an 80 µm median cryosection of PCLS incubated for 24 h with Ag-NPs
(30 µg/mL). Red: signal of lung tissue; green: signal of Ag-NPs aggregates/agglomerates. A: green signal; B: merge of red and green signal. The
arrows mark the upper cut surface, the arrow heads the lower cut surface.
Localization of Ag-NPs in PCLS by using multi-
photon microscopy
To visualize the localization of NPs in PCLS after incubation,
we employed multiphoton microscopy on PCLS exposed to
Ag-NPs. By examining a median cross-cryosection of PCLS in-
cubated with 30 µg/mL Ag-NPs for 24 h, a non-uniform distrib-
ution of Ag-NP aggregates/agglomerates was detected. As
depicted in Figure 7, Ag-NP aggregates/agglomerates were
predominantly localized on the upper cut surface of PCLS, a
small amount on the lower cut surface and only a few Ag-NPs
were found in inner tissue regions.
Discussion
PCLS are already an established ex vivo alternative to in vitro
and in vivo examinations in pharmacotoxicology. The aim of
the present study was to evaluate the potential of PCLS as a tool
in nanotoxicology studies.
First of all, we assessed the viability of PCLS over time by
three different viability assays. The performance of more than
just one viability test is essential as every test measures a
different factor and, additionally, interference of particles with
the test assay has been already described [21,22]. Taken
together, a slight decrease in viability over time was detected
which is also in line with results of previous studies with PCLS
prepared from Wistar rat, guinea pig, and human lung tissue
[10,11,23]. Also the viability of PCLS determined through live/
dead staining slightly decreased over time, but PCLS were
found to be still viable 72 h after preparation. Moreover,
viability of PCLS was determined through WST-1 assay. The
results of the WST-1 assay suggest that the viability of PCLS
was improved 24 h after preparation. As WST-1 conversion is
also an indicator for proliferation, we performed an additional
proliferation assay that did not show significant differences in
proliferation over time. The increase in mitochondrial activity
after 24 h might be explained as recovery of the cells after the
slicing procedure as it has been described already elsewhere
[6,11]. Nevertheless, it has also been reported that the cutting
process possibly induces the release of mitogenic factors that
cause enhanced proliferation [24]. Taken together, the experi-
mental findings of all three viability tests indicate that PCLS, in
our hands, are viable for at least 72 h.
The aim of this study was to determine the suitability of PCLS
as an alternative test system in nanotoxicology. Therefore, we
assessed the cytotoxic and proinflammatory response of PCLS
to Ag-NPs through LDH assay, WST-1 assay, and CXCL-1 and
TNF-α ELISAs. The PVP-coated Ag-NPs used in this study
have been already demonstrated to induce a cytotoxic and/or
proinflammatory response in vivo and in vitro [25,26]. More-
over, ZnO-NPs served as a soluble control and quartz particles
as a non-soluble control, since both particle types have been
shown to elicit cytotoxic as well as inflammatory responses in
both in vitro and in vivo assays [27,28].
Interestingly enough, the PVP-coated Ag-NPs used in this study
only induced a slight cytotoxic, but not an inflammatory
response in PCLS. However, these NPs induced cytotoxicity in
human mesenchymal stem cells and peripheral blood mononu-
clear cells in vitro when incubated at a concentration of
25 µg/mL or higher [29,30]. Additionally, these NPs elicited a
cytotoxic and inflammatory response in rat lungs 24 h after
intratracheal instillation of 80 µL Ag-NPs at a concentration of
250 µg/mL [25]. Furthermore, quartz particles did not appear to
cause a loss in viability or proinflammatory response, although
a cytotoxic and/or inflammatory effect has been described after
exposure to quartz particles in vitro as well as in vivo [28,31-
33]. In particular, Beyerle et al. have demonstrated that quartz
particles (the same as those in the present study) induced a loss
in membrane integrity in vitro in murine alveolar epithelial cells
and macrophages after 24 h of incubation [31]. Furthermore,
cytotoxicity elicited by quartz particles has been shown in vivo
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by evaluation of bronchoalveolar lavage fluids and lung tissue
of rats after intratracheal instillation [24,28]. In contrast, ZnO-
NPs induced a strong cytotoxic effect after 4 and 24 h of incu-
bation, which is in line with results of a previous report [20]. In
this study, cytotoxicity was determined after a 24 h exposure of
PCLS, also prepared from Wistar rats, to ZnO-NPs (the same as
those in our study) or carbon nanotubes that induced either a
marked or no cytotoxic response, respectively. Furthermore, a
strong cytotoxic response after exposure with ZnO-NPs has
been reported in several in vitro and in vivo studies [27,34-37].
However, the loss in viability after ZnO-NP exposure is
presumed to be mainly induced by the release of Zn2+ ions [37].
The dissolution of NPs into toxic ions seems to be an important
factor regarding the toxicity of the material [38,39]. Dissolu-
tion and therefore release of Zn2+ ions in the culture medium
has been already described for the ZnO-NPs used in the present
study [40]. Moreover, the dissolution (50 to 60% within 24 h)
of ZnO-NPs in cell culture medium facilitates an interaction of
Zn2+ ions with cells [27]. Ag-NPs were shown to dissolve after
immersion in water in the presence of oxygen under the release
of Ag+ ions [30,41]. However, their dissolution in biological
environments is still poorly understood and will be influenced
by the presence of biomolecules such as proteins [42,43]. Taken
together, the viability of PCLS only decreased after exposure to
ZnO-NPs, but not after exposure to quartz particles and only
slightly after exposure to Ag-NPs.
Moreover, we determined the proinflammatory response of
PCLS upon particle exposure. Surprisingly, none of the used
materials induced a proinflammatory effect, although ZnO-NPs
as well as quartz particles have been shown to induce inflamma-
tory responses in the lung [27,28,34,36,37]. The low levels of
CXCL-1 and TNF-α after exposure to ZnO-NP are probably
due to the fact that most of the cells are already dead, as deter-
mined by the WST-1 assay. In summary, PCLS did not react
with the release of proinflammatory cytokines upon exposure to
the particles at the concentrations tested here.
The low cytotoxic response to Ag-NPs, the absent cytotoxic
response to quartz particles, and also the non-existent inflam-
matory response to all particles are in contrast to studies using
these particles in conventional in vitro and in vivo assays.
Consequently, the question was whether and to what extent the
particles interacted with the PCLS under submerged conditions.
Therefore, we employed multiphoton microscopy to visualize
the localization of Ag-NPs in and on PCLS after 24 h of incuba-
tion. Recently, our group has demonstrated that third harmonic
generation (THG) microscopy, which is based on optical effects
induced by specific inherent physical properties of a specimen,
allows high-resolution label-free 3D visualization of cellular
and tissue structures in intact muscle of living mice [44]. This
technique allowed us to record images of Ag-NPs and lung
tissue without additional labelling, since Ag-NPs exhibit strong
two-photon-induced photoluminescence and enhanced THG
signals through surface plasmon resonance [45,46]. As shown
by multiphoton microscopy, the Ag-NPs were predominantly
localized at the upper cut surface of PCLS as aggregates/
agglomerates and only at a much lower extent in in deeper
regions of the tissue slice. This indicates that the majority of the
particles did not have the chance to interact with all cells
present in the tissue slice since the Ag-NPs with their hydrody-
namic diameter of 116 nm are too large for diffusional trans-
port through the tissue. In contrast, the Zn2+ ions released by
the ZnO-NPs are able to travel by diffusion, resulting in the
strong cytotoxic response of PCLS we have measured in this
study. These findings suggest that the interaction of non-soluble
NPs with the majority of cells present in a given PCLS appears
to be limited.
Conclusion
Although a recently published study demonstrated that PCLS
are able to detect different early effects of NP toxicity, it is still
not clear whether PCLS possess an added value in detecting
nanomaterial pulmonary toxicity [47]. Here we show that there
was no cytotoxic response of PCLS to micron-sized quartz
particles, only a slight cytotoxic response to PVP-coated
Ag-NPs, but a strong cytotoxic response to uncoated ZnO-NPs.
Moreover, none of the materials induced a proinflammatory
effect in PCLS. Furthermore, we were able to show by multi-
photon microscopy that the majority of Ag-NPs was localized
on the cut surface of the PCLS and not able to translocate into
inner regions of the tissue slice. Based on these findings, we
conclude that PCLS may have some limitations when used in
nanotoxicology studies. However, a definite conclusion can be
only drawn after testing also other types and concentrations of
NPs as well as using other more sensitive analysis methods to
assess possible cell responses.
Experimental
Particles
PVP-coated Ag-NPs were prepared as described before [30,48].
Briefly, Ag-NPs were synthesized by reduction with glucose in
the presence of PVP and dispersed in ultrapure degassed water.
The silver concentration was determined by atomic absorption
spectroscopy (AAS) with a detection limit of 1 μg·L−1. SEM
was performed with a FEI Quanta 400 ESEM instrument in
high vacuum without sputtering. Particle size distribution and
PDI were measured by DLS with a Malvern Zetasizer Nano ZS
(Malvern Instruments GmbH, Herrenberg, Germany).
The uncoated ZnO-NPs NM110 belonged to a set of represen-
tative manufactured nanomaterials provided and characterized
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by the European Commission Joint Research Centre (JRC,
Ispra, Italy). Particle size distribution was determined by DLS.
Shortly before incubation with PCLS, ZnO-NPs were dispersed
following the Nanogenotox dispersion protocol [49].
The quartz particles (Min-U-Sil 5, crystalline silica, α-quartz)
with a purity of 98% SiO2 were obtained from US Silica
Company (Berkeley Springs, WV, USA). Immediately before
incubation with PCLS, quartz particles were dispersed at a
concentration of 1 mg/mL in distilled water. Subsequently, the
suspension was vortexed for 1 min followed by ultrasonic bath
for 1 min. This procedure was repeated three times.
Animals
Female Wistar rats (Wistar RjHan:WI rats), 8–10 weeks of age
(approx. 250 g body weight), were obtained from Janvier (Le
Genest Saint Isle, France). The animals had at least one week
for acclimatization and were housed in pairs in standard
Makrolon plastic cages type IV on a 12 hour day/night circle.
Rodent diet and water were provided ad libitum.
Preparation of PCLS
Under isoflurane anaesthesia, rats were sacrificed by exsan-
guination through the abdominal aorta. Lungs were filled with
15 mL of a 1.5% low gelling temperature agarose solution in
situ. After five minutes the lungs were extracted and cooled in
an ice-cooled Earl’s Balanced Salt Solution for 10 min.
Punched out cylinders (diameter 8 mm) of these lungs were cut
into approximately 250 micrometre thin slices by using a
Krumdieck tissue slicer (microtome; Alabama Research and
Development, Munford, AL, USA). Always four PCLS per well
(24-well plate) were cultured in Dulbecco’s modified Eagle’s
medium/nutrient mixture F-12 Ham (DMEM/F-12 Ham)
containing 100 units/mL penicillin and 100 µg/mL strepto-
mycin. The 24-well plates were placed on a plate shaker in the
incubator (5% CO2, 100% humidity, 37 °C). Prior to incuba-
tion, the PCLS were placed in a 24-well culture dish in the incu-
bator for re-melting the agarose and washed for 1 h by changing
the culture medium three times, in order to remove the agarose.
Incubation of PCLS
For viability testing, PCLS were incubated with 500 µL
DMEM/F-12 Ham for 4, 24, 48, and 72 h. For particle expo-
sure experiments PCLS were exposed for 4 and 24 h to 500 µL
DMEM/F-12 Ham either with PVP-Ag-NPs (10, 20, and
30 µg/mL), 30 µg/mL ZnO-NPs, or 30 µg/mL quartz particles.
Therefore, after the 1 h washing procedure, culture medium
used for washing was replaced by the particular suspension.
Additionally, PCLS were incubated only with 500 µL DMEM/
F-12 or with 500 µL DMEM/F-12 with 1 µg/mL LPS, which
served as negative and positive (inflammatory) control. Further-
more, PCLS were lysed by adding 1% Triton X-100 which was
used as positive (cytotoxic) control. All incubations were
performed in duplicates.
Determination of LDH release in PCLS
culture medium
LDH release was determined in PCLS culture medium using the
Cytotoxicity Detection KitPLUS (LDH) (Roche, Mannheim,
Germany). Triton X-100 lysed PCLS were used as positive
controls (100% LDH release). Results were calculated as
percentage of the total LDH content. All tests were performed
in duplicates.
Live/dead staining
Viability of PCLS was determined after 4, 24, 48, and 72 h by
using the LIVE/DEAD® Viability/Cytotoxicity Kit for
mammalian cells (Invitrogen, Karlsruhe, Germany). PCLS were
incubated with 4 µM calcein acetoxymethyl (calcein AM) and
4 µM ethidium-homodimer-1 (EthD-1) for 45 min at room
temperature. Live cells enzymatically convert calcein AM in
fluorescent calcein, while EthD-1 enters dead cells through the
damaged membrane, binds to their nuclei, and emits red fluo-
rescence. Immediately after the staining procedure, PCLS were
mounted in phosphate buffered saline (PBS) on glass slides and
observed by using a Leica SP5 confocal laser-scanning micro-
scope (cLSM, Leica Microsystems, Wetzlar, Germany) with a
PlanFluotar objective (Leica; 20×; NA 0.5). The excitation
wavelength was 488 nm and the emission was detected at
510–540 nm for calcein and 580–620 nm for EthD-1. Optical
z-sections covering 30 µm depth of the PCLS (z-distance 1 µm)
were recorded by using the same settings for all samples.
Images were processed and analysed with Imaris software
(Bitplane, Zürich Switzerland). For quantification of dead cells,
the Imaris spotfinder algorithm was applied to automatically
identify and count labelled cell nuclei in these 3D volumes and
the volume of live cells was identified and calculated by using
the surface tool. Similarly, as already described in Henjacovic
et al. [8], viability was determined as ratio of nuclei of dead
cells per volume of live cells (spots (diameter ≤ 4 µm)/volume
(105 µm3).
WST-1 reduction in PCLS culture medium
The WST-1 assay (Roche Diagnostics, Mannheim, Germany)
was used for spectrometric quantification of cellular viability.
After removing cell culture medium, PCLS were incubated for
1 h with 500 µL freshly prepared WST-1 solution (manufac-
turer protocol) diluted 1:10 in DMEM/F-12 Ham. Absorbance
was determined at a wavelength of 450 nm. Results are given in
percentage of control. The relative WST-1 conversion was
calculated as percentage of control (WST-1 conversion at 0 h).
All tests were performed in duplicates.
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Cell proliferation assay
For determination of cell proliferation, the Click-iT® EdU
Alexa Fluor® 488 Imaging Kit (Invitrogen, Karlsruhe,
Germany) was used. PCLS were incubated for 4 h with 20 µM
EdU (5-ethynyl-2′-deoxyuridine, a nucleoside analogue to
thymidine) at 0, 20, 44, and 68 h after preparation. Subse-
quently, four PCLS per time point were fixed with buffered
4% paraformaldehyde (Microcos GmbH, Saaldorf-Surheim,
Germany) at room temperature for 15 min. Then PCLS were
washed twice in PBS supplemented with 3% bovine albumin
serum (BSA) and stored at 4 °C until further processing. The
EdU staining was conducted as described by the manufacturer.
Briefly, after permeabilization (with PBS, supplemented with
3% BSA and 0.5% Triton X-100 (Sigma-Aldrich, Munich,
Germany), PCLS were incubated with the EdU Click-iT® reac-
tion cocktail followed by another washing step and finally
mounted in PermaFluor (Thermo Scientific, Fremont, CA,
USA) on a glass slide. Images were acquired with the cLSM
(see details above). Excitation wavelength was 488 nm and
emission was detected at 510–600 nm. Optical z-sections
covering the complete depth of the PCLS (z-size 250 µm, z-dis-
tance 3 µm) were recorded by using the same settings for all
samples. Images were processed and analyzed by using Imaris
software (Bitplane, Zürich, Switzerland). For quantification of
EdU positive cells, the Imaris spotfinder algorithm was applied
to automatically identify and count labelled cell nuclei in three
3D-volumes (xy-size 500 µm, z-size 250 µm) from each PCLS
sample.
Quantification of TNF-α and CXCL-1 in the
PCLS-culture medium by ELISA
The proinflammatory cytokines TNF-α and CXCL-1 were
measured in PCLS supernatants by using commercially avail-
able enzyme-linked immunosorbent assay kits (ELISA, DuoSet,
R&D, Wiesbaden-Nordenstadt, Germany) according to the
specifications of the manufacturer. Absorbance was determined
at a wave length of 450 nm (Tecan Infinite F200).
Multiphoton microscopy
PCLS incubated with 30 µg/mL of Ag-NPs for 24 h were fixed
in 70% ethanol until further processing. Before cryosectioning,
PCLS were embedded in Tissue-Tek OCT compound (Miles,
Inc. Diagnostic Division, Elkhart, IN) and frozen until hard-
ening. Then 60 to 80 µm thick cross sections of PCLS were cut
with a cryostat microtome (Microm HM560, Thermo scientific,
Waltham, MA, USA), transferred on a glass slide, and cover-
slipped immediately.
Two-photon microscopy on PCLS sections incubated with
Ag-NPs (30 µg/mL) was performed on a TriMScope (LaVision
Biotec, Bielefeld, Germany) built around an Olympus BX 51
microscope (Olympus, Hamburg, Germany) and equipped with
a tunable Ultra II Ti:sapphire laser (Coherent, Dieburg,
Germany) and an optical parametric oscillator (Chameleon
OPO; APE, Berlin, Germany), which is pumped by the
Ti:sapphire laser. The OPO generated 1275 nm light with
640–700 mW output. The attenuated intensity at the sample was
170 mW. An Olympus XLUMPlanFl 20×/0.95W objective was
used to acquire optical sections (z-size: 85 µm, z-distance: 1
µm, xy: 500 × 500 µm with 1035 × 1035 pixels and 400 lines
per second).
The Ag-NP signal was (epi-)detected at 604–644 nm, THG
signal was detected in the forward direction at (417–477 nm).
700 nm short pass filters blocked out excitation light. Light
collection in forward direction was performed by an Olympus
WI-UCD condenser, NA 0.8. Photomultiplier tubes were
gallium arsenide phosphide detectors (Hamamatsu H7422-40).
Images were processed and 3D rendered by using Imaris soft-
ware (Bitplane, Zürich, Switzerland).
Statistical analysis
Data in the figures are given as mean ± SEM (standard error of
the mean). Statistical analysis was performed for normalized
data by one-way ANOVA with post hoc Tukey test. Other data
were analyzed by repeated measures ANOVA on ranks fol-
lowed by a post hoc test as stated individually (Software:
SigmaStat for Windows, Jandel Scientific, Erkrath, Germany).
Differences were considered statistically significant at p < 0.05.
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